Cargando…

295. SARS-CoV-2 Associated Multisystem Inflammatory Syndrome in Adults (MIS-A): a Multicenter Case Series.

BACKGROUND: MIS-A frequently presents with symptoms including fevers, cardiovascular, gastrointestinal mucocutaneous, and neurologic involvement in both children and adults. Predominantly occurs in previously healthy children and young adults, disproportionately affecting individuals of African,Lati...

Descripción completa

Detalles Bibliográficos
Autores principales: Trigueros, Ricardo, Denmeade, Travis, Pannebaker, Danielle, Maves, Ryan C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752242/
http://dx.doi.org/10.1093/ofid/ofac492.373
_version_ 1784850671864905728
author Trigueros, Ricardo
Denmeade, Travis
Pannebaker, Danielle
Maves, Ryan C
author_facet Trigueros, Ricardo
Denmeade, Travis
Pannebaker, Danielle
Maves, Ryan C
author_sort Trigueros, Ricardo
collection PubMed
description BACKGROUND: MIS-A frequently presents with symptoms including fevers, cardiovascular, gastrointestinal mucocutaneous, and neurologic involvement in both children and adults. Predominantly occurs in previously healthy children and young adults, disproportionately affecting individuals of African,Latino and Asian descent. Represents one of the most significant and yet under-recognized clinical consequences of SARS-CoV-2 infection. METHODS: A retrospective review was performed of the identified MIS-A cases admitted to two institutions between January 2020-December 2021. Included cases required evidence of present or previous SARS-CoV-2 infection by either PCR or antigen testing; and meeting the CDC definition for MIS-A. After case identification, we collected clinical and laboratory data to analyze demographics, clinical symptoms, laboratory result, imaging, length of hospitalization and therapeutic interventions. RESULTS: Ten cases were identified in the established period of time. The average interval to hospital admission was 31days. Clinical symptoms included fever, malaise, gastrointestinal complaints, dyspnea, diffuse rash. Males outnumbered females in a ratio of 7:3,with African American and Latino patients comprising 80% of the cases. All patients had elevated inflammatory markers and the most commonly manifesting organ dysfunction was cardiovascular system. [Figure: see text] [Figure: see text] [Figure: see text] CONCLUSION: This case series helps reinforce the characterization of an as yet incompletely understood and challenging clinical syndrome, providing insight to guide diagnosis and treatment of MIS-A. A greater understanding of MIS-A may facilitate earlier syndromic recognition in order to improve outcomes, reduce unnecessary antimicrobial use, and reduce costs. [Figure: see text] DISCLOSURES: Ryan C. Maves, MD, AiCuris: Grant/Research Support|Sound Pharmaceuticals: Grant/Research Support|Trauma Insights, LLC: Advisor/Consultant.
format Online
Article
Text
id pubmed-9752242
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-97522422022-12-16 295. SARS-CoV-2 Associated Multisystem Inflammatory Syndrome in Adults (MIS-A): a Multicenter Case Series. Trigueros, Ricardo Denmeade, Travis Pannebaker, Danielle Maves, Ryan C Open Forum Infect Dis Abstracts BACKGROUND: MIS-A frequently presents with symptoms including fevers, cardiovascular, gastrointestinal mucocutaneous, and neurologic involvement in both children and adults. Predominantly occurs in previously healthy children and young adults, disproportionately affecting individuals of African,Latino and Asian descent. Represents one of the most significant and yet under-recognized clinical consequences of SARS-CoV-2 infection. METHODS: A retrospective review was performed of the identified MIS-A cases admitted to two institutions between January 2020-December 2021. Included cases required evidence of present or previous SARS-CoV-2 infection by either PCR or antigen testing; and meeting the CDC definition for MIS-A. After case identification, we collected clinical and laboratory data to analyze demographics, clinical symptoms, laboratory result, imaging, length of hospitalization and therapeutic interventions. RESULTS: Ten cases were identified in the established period of time. The average interval to hospital admission was 31days. Clinical symptoms included fever, malaise, gastrointestinal complaints, dyspnea, diffuse rash. Males outnumbered females in a ratio of 7:3,with African American and Latino patients comprising 80% of the cases. All patients had elevated inflammatory markers and the most commonly manifesting organ dysfunction was cardiovascular system. [Figure: see text] [Figure: see text] [Figure: see text] CONCLUSION: This case series helps reinforce the characterization of an as yet incompletely understood and challenging clinical syndrome, providing insight to guide diagnosis and treatment of MIS-A. A greater understanding of MIS-A may facilitate earlier syndromic recognition in order to improve outcomes, reduce unnecessary antimicrobial use, and reduce costs. [Figure: see text] DISCLOSURES: Ryan C. Maves, MD, AiCuris: Grant/Research Support|Sound Pharmaceuticals: Grant/Research Support|Trauma Insights, LLC: Advisor/Consultant. Oxford University Press 2022-12-15 /pmc/articles/PMC9752242/ http://dx.doi.org/10.1093/ofid/ofac492.373 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstracts
Trigueros, Ricardo
Denmeade, Travis
Pannebaker, Danielle
Maves, Ryan C
295. SARS-CoV-2 Associated Multisystem Inflammatory Syndrome in Adults (MIS-A): a Multicenter Case Series.
title 295. SARS-CoV-2 Associated Multisystem Inflammatory Syndrome in Adults (MIS-A): a Multicenter Case Series.
title_full 295. SARS-CoV-2 Associated Multisystem Inflammatory Syndrome in Adults (MIS-A): a Multicenter Case Series.
title_fullStr 295. SARS-CoV-2 Associated Multisystem Inflammatory Syndrome in Adults (MIS-A): a Multicenter Case Series.
title_full_unstemmed 295. SARS-CoV-2 Associated Multisystem Inflammatory Syndrome in Adults (MIS-A): a Multicenter Case Series.
title_short 295. SARS-CoV-2 Associated Multisystem Inflammatory Syndrome in Adults (MIS-A): a Multicenter Case Series.
title_sort 295. sars-cov-2 associated multisystem inflammatory syndrome in adults (mis-a): a multicenter case series.
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752242/
http://dx.doi.org/10.1093/ofid/ofac492.373
work_keys_str_mv AT triguerosricardo 295sarscov2associatedmultisysteminflammatorysyndromeinadultsmisaamulticentercaseseries
AT denmeadetravis 295sarscov2associatedmultisysteminflammatorysyndromeinadultsmisaamulticentercaseseries
AT pannebakerdanielle 295sarscov2associatedmultisysteminflammatorysyndromeinadultsmisaamulticentercaseseries
AT mavesryanc 295sarscov2associatedmultisysteminflammatorysyndromeinadultsmisaamulticentercaseseries